Moreover, the density of OVA257-246-H-2Kb-specific tumour-resident CD103+ CD11b− cDC1s in the hydrogel microsphere vaccine-treated tumour was over fivefold higher than that in Group1-treated control mice (Fig. 4n and Supplementary Fig. 12). This evidence concerns the gene ITGAM and neoplasm.